December 20, 2025 01:22 am (IST)
Colgate reports 12% increase in 1H net sales
Mumbai, Nov 5 (IBNS): Colgate-Palmolive (India) Limited on Wednesday reported net sales of Rs. 1,944.2 crore for the half year ended September 30, 2014, a 12% increase over the same period of the previous year.
The company registered a Net Profit After Tax of Rs. 264.5 crore with Earnings Per Share of Rs. 19.45, an increase of 11% over the same period of the previous year excluding exceptional item in the previous year relating to the slump sale of Global Shared Services Organisation to Colgate Global Business Services Private Limited, a 100% subsidiary of Colgate-Palmolive Company, USA.
The company reported net sales of Rs. 993.6 crore for the second quarter of the financial year 2014-15, a 11% increase over the same quarter of the previous year.
While, the Net Profit After Tax for the second quarter was Rs. 129.6 crore with Earnings Per Share of Rs. 9.53, an increase of 18% over the same quarter of the previous year.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Tata AIA launches multicap opportunities fund
Fri, Dec 19 2025
IPO fireworks! ICICI Prudential AMC pops 20% on market debut
Fri, Dec 19 2025
Bharti Airtel announces top leadership changes; Gopal Vittal to become Executive Vice Chairman
Thu, Dec 18 2025
TCS bets big on AI, shares spike as company reveals ambitious plan
Thu, Dec 18 2025
Meesho’s wild ride: Hits record market cap, then suddenly slides
Thu, Dec 18 2025
SBI rolls out YONO 2.0! Banking gets a major digital upgrade
Wed, Dec 17 2025
Nephrocare IPO pops on debut, dialysis major lists at 7% premium
Wed, Dec 17 2025
